139 related articles for article (PubMed ID: 32234332)
1. 2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1).
Yu J; Zhong B; Jin L; Hou Y; Ai N; Ge W; Li L; Liu S; Lu JJ; Chen X
Free Radic Biol Med; 2020 May; 152():336-347. PubMed ID: 32234332
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis.
Zhong B; Yu J; Hou Y; Ai N; Ge W; Lu JJ; Chen X
Free Radic Biol Med; 2021 Apr; 166():104-115. PubMed ID: 33600944
[TBL] [Abstract][Full Text] [Related]
3. Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis.
Yu J; Zhong B; Zhao L; Hou Y; Ai N; Lu JJ; Ge W; Chen X
Drug Resist Updat; 2023 Sep; 70():100977. PubMed ID: 37321064
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Lung Cancer by 2-Methoxy-6-Acetyl-7-Methyljuglone Through Induction of Necroptosis by Targeting Receptor-Interacting Protein 1.
Sun W; Yu J; Gao H; Wu X; Wang S; Hou Y; Lu JJ; Chen X
Antioxid Redox Signal; 2019 Jul; 31(2):93-108. PubMed ID: 30556404
[No Abstract] [Full Text] [Related]
5. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway.
Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
[TBL] [Abstract][Full Text] [Related]
6. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis.
Huang X; Dong Y; Bey EA; Kilgore JA; Bair JS; Li LS; Patel M; Parkinson EI; Wang Y; Williams NS; Gao J; Hergenrother PJ; Boothman DA
Cancer Res; 2012 Jun; 72(12):3038-47. PubMed ID: 22532167
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.
Sun W; Wu X; Gao H; Yu J; Zhao W; Lu JJ; Wang J; Du G; Chen X
Free Radic Biol Med; 2017 Jul; 108():433-444. PubMed ID: 28414098
[TBL] [Abstract][Full Text] [Related]
8. NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
Li LS; Reddy S; Lin ZH; Liu S; Park H; Chun SG; Bornmann WG; Thibodeaux J; Yan J; Chakrabarti G; Xie XJ; Sumer BD; Boothman DA; Yordy JS
Mol Cancer Ther; 2016 Jul; 15(7):1757-67. PubMed ID: 27196777
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma.
Lei K; Gu X; Alvarado AG; Du Y; Luo S; Ahn EH; Kang SS; Ji B; Liu X; Mao H; Fu H; Kornblum HI; Jin L; Li H; Ye K
J Hematol Oncol; 2020 Oct; 13(1):141. PubMed ID: 33087132
[TBL] [Abstract][Full Text] [Related]
10. Sulindac compounds facilitate the cytotoxicity of β-lapachone by up-regulation of NAD(P)H quinone oxidoreductase in human lung cancer cells.
Kung HN; Weng TY; Liu YL; Lu KS; Chau YP
PLoS One; 2014; 9(2):e88122. PubMed ID: 24505400
[TBL] [Abstract][Full Text] [Related]
11. Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
Cao L; Li LS; Spruell C; Xiao L; Chakrabarti G; Bey EA; Reinicke KE; Srougi MC; Moore Z; Dong Y; Vo P; Kabbani W; Yang CR; Wang X; Fattah F; Morales JC; Motea EA; Bornmann WG; Yordy JS; Boothman DA
Antioxid Redox Signal; 2014 Jul; 21(2):237-50. PubMed ID: 24512128
[TBL] [Abstract][Full Text] [Related]
12. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
Dehn DL; Siegel D; Zafar KS; Reigan P; Swann E; Moody CJ; Ross D
Mol Cancer Ther; 2006 Jul; 5(7):1702-9. PubMed ID: 16891456
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.
Choi EK; Terai K; Ji IM; Kook YH; Park KH; Oh ET; Griffin RJ; Lim BU; Kim JS; Lee DS; Boothman DA; Loren M; Song CW; Park HJ
Neoplasia; 2007 Aug; 9(8):634-42. PubMed ID: 17786182
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein.
Li WY; Zhou HZ; Chen Y; Cai XF; Tang H; Ren JH; Wai Wong VK; Kwan Law BY; Chen Y; Cheng ST; Yu HB; Cai HY; Chen WX; Tang N; Zhang WL; Tao NN; Yang QX; Ren F; He L; Jiang H; Huang AL; Chen J
Cancer Lett; 2019 Jun; 451():156-167. PubMed ID: 30867140
[TBL] [Abstract][Full Text] [Related]
15. Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis.
Ahn KS; Sethi G; Jain AK; Jaiswal AK; Aggarwal BB
J Biol Chem; 2006 Jul; 281(29):19798-808. PubMed ID: 16682409
[TBL] [Abstract][Full Text] [Related]
16. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
Pradubyat N; Sakunrangsit N; Mutirangura A; Ketchart W
Phytomedicine; 2020 Jan; 66():153133. PubMed ID: 31790893
[TBL] [Abstract][Full Text] [Related]
17. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
18. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
Srijiwangsa P; Ponnikorn S; Na-Bangchang K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
[TBL] [Abstract][Full Text] [Related]
19. 2-Methoxy-6-acetyl-7-methyljuglone (MAM), a natural naphthoquinone, induces NO-dependent apoptosis and necroptosis by H2O2-dependent JNK activation in cancer cells.
Sun W; Bao J; Lin W; Gao H; Zhao W; Zhang Q; Leung CH; Ma DL; Lu J; Chen X
Free Radic Biol Med; 2016 Mar; 92():61-77. PubMed ID: 26802903
[TBL] [Abstract][Full Text] [Related]
20. Redox modulation of NQO1.
Siegel D; Dehn DD; Bokatzian SS; Quinn K; Backos DS; Di Francesco A; Bernier M; Reisdorph N; de Cabo R; Ross D
PLoS One; 2018; 13(1):e0190717. PubMed ID: 29298345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]